PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.21%
Revenue growth under 50% of VALMT.HE's 11.94%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
15.43%
Gross profit growth above 1.5x VALMT.HE's 2.94%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
96.75%
EBIT growth above 1.5x VALMT.HE's 47.62%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
96.75%
Operating income growth above 1.5x VALMT.HE's 47.62%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
133.94%
Net income growth above 1.5x VALMT.HE's 46.67%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
150.00%
EPS growth above 1.5x VALMT.HE's 45.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
150.00%
Diluted EPS growth above 1.5x VALMT.HE's 45.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-6.43%
Share reduction while VALMT.HE is at 1.48%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-6.43%
Reduced diluted shares while VALMT.HE is at 1.48%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-9.63%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-31.92%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-45.85%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 69.67%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-4.11%
Negative 5Y CAGR while VALMT.HE stands at 16.53%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
12.57%
3Y revenue/share CAGR similar to VALMT.HE's 13.15%. Walter Schloss would assume both companies experience comparable short-term cycles.
354.26%
10Y OCF/share CAGR under 50% of VALMT.HE's 1758.71%. Michael Burry would worry about a persistent underperformance in cash creation.
37.09%
Below 50% of VALMT.HE's 777.35%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
119.88%
3Y OCF/share CAGR under 50% of VALMT.HE's 381.56%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
600.00%
Below 50% of VALMT.HE's 2800.00%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-0.00%
Negative 5Y net income/share CAGR while VALMT.HE is 106.96%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
66.67%
3Y net income/share CAGR similar to VALMT.HE's 61.11%. Walter Schloss would attribute it to shared growth factors or demand patterns.
3.68%
Below 50% of VALMT.HE's 50.45%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
33.38%
5Y equity/share CAGR above 1.5x VALMT.HE's 17.77%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
31.55%
3Y equity/share CAGR above 1.5x VALMT.HE's 8.95%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
129.06%
5Y dividend/share CAGR at 50-75% of VALMT.HE's 180.31%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
42.58%
3Y dividend/share CAGR at 50-75% of VALMT.HE's 64.77%. Martin Whitman might see a weaker short-term approach to distributing cash.
2.44%
Our AR growth while VALMT.HE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
6.19%
Inventory growth of 6.19% while VALMT.HE is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
-1.35%
Negative asset growth while VALMT.HE invests at 2.04%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.07%
Positive BV/share change while VALMT.HE is negative. John Neff sees a clear edge over a competitor losing equity.
4.18%
Debt shrinking faster vs. VALMT.HE's 46.15%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
No Data
No Data available this quarter, please select a different quarter.
10.87%
We expand SG&A while VALMT.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.